University of California-Irvine Medical Center

Irvine, California 92868

6 studies enrolling now · 21 studies all time

What they study most

Advanced Renal Cell Carcinoma, Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS), Angelman Syndrome, Breast Cancer, Breast Tumor, Colorectal Cancer, Congestive Heart Failure, Dyskinesia, Drug-Induced, Dyskinesias, Epilepsy, Epilepsy (Treatment Refractory)

Studies at this site

• LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve — Recruiting now
• Diagnosing Epilepsy To EffeCT Change — Recruiting now
• Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis — Recruiting now
• Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD) — Recruiting now
• Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma — Recruiting now
• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
• ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study — Running, not enrolling
• Study of DF1001 in Patients With Advanced Solid Tumors — Completed
• P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors — Running, not enrolling
• A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases — Completed
• Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma — Completed
• Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure — Running, not enrolling
• Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy — Stopped early
• A Study of TAK-071 in People With Parkinson Disease — Completed
• Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI — Withdrawn before enrolling
• Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) — Completed
• Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma — Stopped early
• A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE) — Completed
• Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW — Completed
• CATIE-Alzheimer's Disease Trial — Completed
• A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS — Completed